CYRANO THERAPEUTICS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2014-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Study of CYR-064 Versus Placebo in Patients.
Phase 2
Active, not recruiting
- Conditions
- Hyposmia
- First Posted Date
- 2023-08-31
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Cyrano Therapeutics, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT06019000
- Locations
- 🇺🇸
Colorado ENT & Allergy, Colorado Springs, Colorado, United States
🇺🇸ENTAAFL, Port Saint Lucie, Florida, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
News
No news found